Taysha Gene Total Debt vs. Earnings Per Share
| TSHA Stock | USD 3.08 0.16 4.94% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.0048 | 0.0054 |
|
|
For Taysha Gene profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Taysha Gene to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Taysha Gene Therapies utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Taysha Gene's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Taysha Gene Therapies over time as well as its relative position and ranking within its peers.
Taysha |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Taysha Gene. If investors know Taysha will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Taysha Gene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.63 | Revenue Per Share 0.042 | Quarterly Revenue Growth (0.62) | Return On Assets (0.27) | Return On Equity (1.15) |
The market value of Taysha Gene Therapies is measured differently than its book value, which is the value of Taysha that is recorded on the company's balance sheet. Investors also form their own opinion of Taysha Gene's value that differs from its market value or its book value, called intrinsic value, which is Taysha Gene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Taysha Gene's market value can be influenced by many factors that don't directly affect Taysha Gene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Taysha Gene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Taysha Gene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Taysha Gene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Taysha Gene Therapies Earnings Per Share vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Taysha Gene's current stock value. Our valuation model uses many indicators to compare Taysha Gene value to that of its competitors to determine the firm's financial worth. Taysha Gene Therapies is rated third in total debt category among its peers. It is currently regarded as top stock in earnings per share category among its peers . The ratio of Total Debt to Earnings Per Share for Taysha Gene Therapies is about 96,995,238 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Taysha Gene's earnings, one of the primary drivers of an investment's value.Taysha Total Debt vs. Competition
Taysha Gene Therapies is rated third in total debt category among its peers. Total debt of Health Care industry is at this time estimated at about 613.93 Million. Taysha Gene holds roughly 61.11 Million in total debt claiming about 10% of equities under Health Care industry.
Taysha Earnings Per Share vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Taysha Gene |
| = | 61.11 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Taysha Gene |
| = | 0.63 X |
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
Taysha Earnings Per Share Comparison
Taysha Gene is currently under evaluation in earnings per share category among its peers.
Taysha Gene Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Taysha Gene, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Taysha Gene will eventually generate negative long term returns. The profitability progress is the general direction of Taysha Gene's change in net profit over the period of time. It can combine multiple indicators of Taysha Gene, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -72.4 M | -76.1 M | |
| Income Before Tax | -111.6 M | -117.1 M | |
| Net Loss | -157.1 M | -149.2 M | |
| Net Loss | -111.6 M | -117.1 M | |
| Income Tax Expense | 1.2 M | 1.3 M | |
| Net Interest Income | -3.7 M | -3.6 M | |
| Interest Income | 1.9 M | 1.9 M | |
| Net Loss | -214.4 M | -225.1 M | |
| Non Operating Income Net Other | -15.3 M | -16.1 M | |
| Total Other Income Expense Net | -39.1 M | -37.2 M | |
| Change To Netincome | 66.6 M | 70 M | |
| Net Loss | (0.96) | (1.01) | |
| Income Quality | 0.65 | 0.38 | |
| Net Income Per E B T | 0.92 | 0.73 |
Taysha Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Taysha Gene. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Taysha Gene position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Taysha Gene's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Taysha Gene without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Use Investing Themes to Complement your Taysha Gene position
In addition to having Taysha Gene in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Gold ETFs Thematic Idea Now
Gold ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Gold ETFs theme has 19 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Gold ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
To fully project Taysha Gene's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Taysha Gene Therapies at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Taysha Gene's income statement, its balance sheet, and the statement of cash flows.